Biomedreports - biomedreports.com - Biotech and Healthcare Stock Market News - Stocks to Watch from BioMedReports.com
General Information:
Latest News:
Dendreon: Too Little, Too Late? 27 Aug 2013 | 09:23 am
Dendreon (NASDAQ: DNDN)’s last two years of trading could be considered the stock market’s version of a slow motion train wreck.
Acura Says Results from Top-Line Study 'Not Statistically Significant'; Rigel Announces R343 Did Not Meet Endpoints in Asthma Trial 27 Aug 2013 | 09:12 am
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 26, 2013.
Healthcare Review: Amgen, BioCryst, Compugen, ResMed, Rigel Pharmaceuticals 27 Aug 2013 | 08:26 am
U.S. stocks opened little changed on Monday after data showed a steep drop in orders for long-lasting manufactured goods last month.
Ampio Momentum Continues After Positive Initial Phase III Data 26 Aug 2013 | 05:53 pm
Recently presented data from a 329 patient Phase III trial for its lead candidate Ampion sent shares of Ampio Pharmaceuticals (NASDAQ: AMPE) sharply higher.
ChemoCentryx Says Glaxo's Results from Study of Vercirnon Did Not Meet Primary Endpoint 24 Aug 2013 | 05:35 am
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 23, 2013.
Healthcare Review: Galena Biopharma, Zimmer Holdings, Amgen, ChemoCentryx, Teva 24 Aug 2013 | 04:21 am
Treasuries and U.S. stocks rose as a report showing a plunge in home sales eased concern the Federal Reserve will cut stimulus efforts next month.
Nymox Issues Results on NX02-0018 Phase Trial; OncoMed Granted Patent for Methods of Treating Cancer 23 Aug 2013 | 05:18 am
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 22, 2013.
Healthcare Review: Coronado Biosciences, Horizon Pharma, XOMA, Prana Biotechnology, Gentium 23 Aug 2013 | 04:01 am
Trading was halted on the Nasdaq stock exchange on Thursday because of technical problems while U.S. stocks rose slightly. All traffic through Nasdaq stopped at 12:14 p.m. (1614 GMT), the exchange sai...
Boston Scientific Wins FDA Approval for IntellaTip MiFi XP Ablation Catheter; Incyte Issues Top-Line Results of Phase II PoC Trial of Ruxolitinib 22 Aug 2013 | 05:37 am
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 21, 2013.
Healthcare Review: Edwards Lifesciences, Allergan, Questcor Pharmaceuticals, Navidea Biopharmaceuticals, Repros Therapeutics 22 Aug 2013 | 04:29 am
Normal 0 false false false EN-US X-NONE X-NONE U.S. stocks fell, with the Dow Jones Industrial Average on track for its longest slump in 13 months, as the Federal Reserve’s July meeting minute...
